Abstract

Clostridium difficile toxins A and B are major virulence factors responsible for induction of pseudomembranous colitis and antibiotic-associated diarrhea in men. The toxins possess a multidomain structure and only the N-terminal glucosyltransferase domain, which inactivates Rho GTPases by glucosylation, is translocated into the cytosol of target cells. Processing of the toxin occurs by autocatalytic cleavage and is activated by inositol hexakisphosphate (InsP6). Here we studied the inherent protease activity in fragments of toxin B and determined the site of toxin B that interacts with InsP6. We report that a fragment of toxin B, comprised of residues 1-955, is cleaved in the presence of InsP6. In contrast, mutants of the catalytic triad of the putative cysteine protease domain did not cleave this fragment. [3H]InsP6 bound to holotoxin B and to the fragment 1-955, but not to a fragment comprising residues 900-2366 or the glucosyltransferase domain (residues 1-544). Binding to the putative cysteine protease domain (residues 544-955) was also observed. InsP6-binding was specific and saturable. Isothermal titration calorimetry revealed a Kd value of 2.4 microm for binding of InsP6 to toxin fragment 544-955 with a stoichiometry factor of 0.86. Lysine 600 of toxin B was identified as essential amino acid for InsP6 binding and for InsP6-dependent activation of the protease activity.

Highlights

  • Clostridium difficile toxins A and B are the causative agents of pseudomembranous colitis

  • The concentration of InsP6 to stimulate autocleavage was in the same range as observed previously for autocatalytic cleavage of the holotoxin [12] starting at ϳ1 ␮M

  • Clostridial glucosylating toxins are processed by autocatalytic cleavage

Read more

Summary

EXPERIMENTAL PROCEDURES

Bacterial Strains and Reagents—Escherichia coli BL21(DE3) (Invitrogen, Karlsruhe, Germany) and TG1 bacteria (Stratagene, La Jolla, CA) were cultivated in LB-broth (Luria/Miller; Carl Roth GmbH, Karlsruhe, Germany) at 37 °C if not otherwise mentioned. Oligonucleotides were purchased from Apara Bioscience GmbH (Freiburg, Germany). Toxin B specific primers for site-directed mutagenesis to generate the following amino acid substitutions: K600E, K689E, R751E/R752E, and H653A/C698A, were designed according to the cDNA sequence of toxin B from C. difficile strain VPI 10463 Myo-inositol 1,4,5-trisphosphate, myo-inositol hexasulfate, proteinase K, and thrombin were purchased from Sigma-Aldrich, benzamidine-Sepharose

The abbreviations used are
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call